BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35151084)

  • 1. Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking.
    Gozdzialski L; Rowley A; Borden SA; Saatchi A; Gill CG; Wallace B; Hore DK
    Int J Drug Policy; 2022 Apr; 102():103611. PubMed ID: 35151084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portable gas chromatography-mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples.
    Gozdzialski L; Aasen J; Larnder A; Ramsay M; Borden SA; Saatchi A; Gill CG; Wallace B; Hore DK
    Int J Drug Policy; 2021 Nov; 97():103409. PubMed ID: 34392112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; SocĂ­as ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies.
    Bhuiyan I; Tobias S; Ti L
    Am J Drug Alcohol Abuse; 2023 Nov; 49(6):685-690. PubMed ID: 37506334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations.
    Gozdzialski L; Wallace B; Hore D
    Harm Reduct J; 2023 Mar; 20(1):39. PubMed ID: 36966319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in the unregulated opioid market in the context of extreme rates of overdose.
    Larnder A; Saatchi A; Borden SA; Moa B; Gill CG; Wallace B; Hore D
    Drug Alcohol Depend; 2022 Jun; 235():109427. PubMed ID: 35405459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.
    Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG
    Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
    Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
    Crepeault H; Socias ME; Tobias S; Lysyshyn M; Custance A; Shapiro A; Ti L
    Drug Alcohol Rev; 2023 Mar; 42(3):538-543. PubMed ID: 36423900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid SERS Quantification of Trace Fentanyl Laced in Recreational Drugs with a Portable Raman Module.
    Wang H; Xue Z; Wu Y; Gilmore J; Wang L; Fabris L
    Anal Chem; 2021 Jul; 93(27):9373-9382. PubMed ID: 34191499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and Quantitation of Trace Fentanyl in Heroin by Surface-Enhanced Raman Spectroscopy.
    Haddad A; Comanescu MA; Green O; Kubic TA; Lombardi JR
    Anal Chem; 2018 Nov; 90(21):12678-12685. PubMed ID: 30247896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etizolam: A rapid review on pharmacology, non-medical use and harms.
    Nielsen S; McAuley A
    Drug Alcohol Rev; 2020 May; 39(4):330-336. PubMed ID: 32243020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Confirmation of Fentanyls on Paper using Portable Surface Enhanced Raman Spectroscopy and Paper Spray Ionization Mass Spectrometry.
    Fedick PW; Pu F; Morato NM; Cooks RG
    J Am Soc Mass Spectrom; 2020 Mar; 31(3):735-741. PubMed ID: 32126777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Semi-quantitative method for the detection of fentanyl using surface-enhanced Raman scattering (SERS) with a handheld Raman instrument.
    Smith M; Logan M; Bazley M; Blanchfield J; Stokes R; Blanco A; McGee R
    J Forensic Sci; 2021 Mar; 66(2):505-519. PubMed ID: 33136303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etizolam Blood Concentrations in 191 Forensic Cases in Ontario, Canada (2019-2020).
    Watts C; Martin TL
    J Anal Toxicol; 2022 Aug; 46(7):719-725. PubMed ID: 34570874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting.
    McCrae K; Tobias S; Grant C; Lysyshyn M; Laing R; Wood E; Ti L
    Drug Alcohol Rev; 2020 Jan; 39(1):98-102. PubMed ID: 31746056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug checking identifies counterfeit alprazolam tablets.
    Tobias S; Shapiro AM; Grant CJ; Patel P; Lysyshyn M; Ti L
    Drug Alcohol Depend; 2021 Jan; 218():108300. PubMed ID: 33127185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.